These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20100290)

  • 1. Systematic review of statins for the prevention of vascular dementia or dementia.
    Muangpaisan W; Brayne C;
    Geriatr Gerontol Int; 2010 Apr; 10(2):199-208. PubMed ID: 20100290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and vascular dementia: a review.
    Giannopoulos S; Katsanos AH; Kosmidou M; Tsivgoulis G
    J Alzheimers Dis; 2014; 42 Suppl 3():S315-20. PubMed ID: 24662103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for the treatment of dementia.
    McGuinness B; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007514. PubMed ID: 25004278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for the treatment of dementia.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for the prevention of dementia.
    McGuinness B; Craig D; Bullock R; Passmore P
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003160. PubMed ID: 19370582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.
    Pertzov B; Eliakim-Raz N; Atamna H; Trestioreanu AZ; Yahav D; Leibovici L
    Clin Microbiol Infect; 2019 Mar; 25(3):280-289. PubMed ID: 30472427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.
    Chu CS; Tseng PT; Stubbs B; Chen TY; Tang CH; Li DJ; Yang WC; Chen YW; Wu CK; Veronese N; Carvalho AF; Fernandes BS; Herrmann N; Lin PY
    Sci Rep; 2018 Apr; 8(1):5804. PubMed ID: 29643479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins use and risk of depression: a systematic review and meta-analysis.
    Parsaik AK; Singh B; Murad MH; Singh K; Mascarenhas SS; Williams MD; Lapid MI; Richardson JW; West CP; Rummans TA
    J Affect Disord; 2014 May; 160():62-7. PubMed ID: 24370264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochrane review on 'Statins for the treatment of dementia'.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):119-26. PubMed ID: 22473869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.
    Kunutsor SK; Seidu S; Khunti K
    Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A revised systematic review and meta-analysis on the effect of statins on D-dimer levels.
    Schol-Gelok S; Morelli F; Arends LR; Boersma E; Kruip MJHA; Versmissen J; van Gelder T
    Eur J Clin Invest; 2019 Aug; 49(8):e13130. PubMed ID: 31112290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis.
    Yang Z; Wang H; Edwards D; Ding C; Yan L; Brayne C; Mant J
    Ageing Res Rev; 2020 Jan; 57():100962. PubMed ID: 31505259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of statin use with risk of dementia: a meta-analysis of prospective cohort studies.
    Song Y; Nie H; Xu Y; Zhang L; Wu Y
    Geriatr Gerontol Int; 2013 Oct; 13(4):817-24. PubMed ID: 23461525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis.
    Davis KAS; Bishara D; Perera G; Molokhia M; Rajendran L; Stewart RJ
    J Am Geriatr Soc; 2020 Mar; 68(3):650-658. PubMed ID: 32039479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia.
    Waldman A; Kritharides L
    Drugs; 2003; 63(2):139-52. PubMed ID: 12515562
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.